H.R. 10628

Biosimilars Access and Affordability Act

9 cosponsors

Donald G. Davis
Jake Auchincloss
Jimmy Panetta
John Joyce
Kevin Mullin
Linda T. Sánchez
Nathaniel Moran
Rudy Yakym III
Scott H. Peters

Where it stands

Introduced Sep 28
Committee Now
House of Representatives —
Senate —
Law —

Introduced Sep 28
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Sep 28)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

Sec. 2. Change of when biosimilars are eligible for price negotiations